This work will provide a deeper understanding of the molecular insights of YBX1 in oncogenesis and lay the foundation for the continued development of novel therapeutic strategies for MYC-driven medulloblastoma by harnessing their discovery of a MYC-YBX1-PRC2 axis. This evidence concerns the gene MYC and medulloblastoma.